Tenon Medical Statistics
Total Valuation
Tenon Medical has a market cap or net worth of $9.01 million. The enterprise value is $5.40 million.
Important Dates
The next estimated earnings date is Tuesday, May 12, 2026, after market close.
| Earnings Date | May 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Tenon Medical has 11.30 million shares outstanding. The number of shares has increased by 508.24% in one year.
| Current Share Class | 11.30M |
| Shares Outstanding | 11.30M |
| Shares Change (YoY) | +508.24% |
| Shares Change (QoQ) | +18.70% |
| Owned by Insiders (%) | 7.03% |
| Owned by Institutions (%) | 4.49% |
| Float | 10.15M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.29 |
| Forward PS | 1.38 |
| PB Ratio | 4.40 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.37 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.11, with a Debt / Equity ratio of 0.03.
| Current Ratio | 2.11 |
| Quick Ratio | 1.70 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -228.06% and return on invested capital (ROIC) is -129.67%.
| Return on Equity (ROE) | -228.06% |
| Return on Assets (ROA) | -72.88% |
| Return on Invested Capital (ROIC) | -129.67% |
| Return on Capital Employed (ROCE) | -159.18% |
| Weighted Average Cost of Capital (WACC) | 10.93% |
| Revenue Per Employee | $151,692 |
| Profits Per Employee | -$482,923 |
| Employee Count | 26 |
| Asset Turnover | 0.38 |
| Inventory Turnover | 1.91 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -28.75% in the last 52 weeks. The beta is 1.25, so Tenon Medical's price volatility has been higher than the market average.
| Beta (5Y) | 1.25 |
| 52-Week Price Change | -28.75% |
| 50-Day Moving Average | 0.78 |
| 200-Day Moving Average | 1.05 |
| Relative Strength Index (RSI) | 52.87 |
| Average Volume (20 Days) | 100,139 |
Short Selling Information
The latest short interest is 246,187, so 2.18% of the outstanding shares have been sold short.
| Short Interest | 246,187 |
| Short Previous Month | 191,044 |
| Short % of Shares Out | 2.18% |
| Short % of Float | 2.43% |
| Short Ratio (days to cover) | 1.30 |
Income Statement
In the last 12 months, Tenon Medical had revenue of $3.94 million and -$12.56 million in losses. Loss per share was -$1.70.
| Revenue | 3.94M |
| Gross Profit | 2.36M |
| Operating Income | -12.01M |
| Pretax Income | -12.56M |
| Net Income | -12.56M |
| EBITDA | -11.76M |
| EBIT | -12.01M |
| Loss Per Share | -$1.70 |
Full Income StatementBalance Sheet
The company has $3.76 million in cash and $141,000 in debt, with a net cash position of $3.62 million or $0.32 per share.
| Cash & Cash Equivalents | 3.76M |
| Total Debt | 141,000 |
| Net Cash | 3.62M |
| Net Cash Per Share | $0.32 |
| Equity (Book Value) | 5.04M |
| Book Value Per Share | 0.18 |
| Working Capital | 3.56M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$10.75 million and capital expenditures -$1.02 million, giving a free cash flow of -$11.77 million.
| Operating Cash Flow | -10.75M |
| Capital Expenditures | -1.02M |
| Depreciation & Amortization | 257,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -11.77M |
| FCF Per Share | -$1.04 |
Full Cash Flow StatementMargins
| Gross Margin | 59.79% |
| Operating Margin | -304.59% |
| Pretax Margin | -318.36% |
| Profit Margin | n/a |
| EBITDA Margin | -298.07% |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Tenon Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -508.24% |
| Shareholder Yield | n/a |
| Earnings Yield | -139.29% |
| FCF Yield | -130.55% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | 275.94% |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | 63.84% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on September 6, 2024. It was a reverse split with a ratio of 1:8.
| Last Split Date | Sep 6, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:8 |
Scores
Tenon Medical has an Altman Z-Score of -12.58 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -12.58 |
| Piotroski F-Score | 2 |
